217 related articles for article (PubMed ID: 29304072)
1. Potential drug-drug interactions and their risk factors in pediatric patients admitted to the emergency department of a tertiary care hospital in Mexico.
Morales-Ríos O; Jasso-Gutiérrez L; Reyes-López A; Garduño-Espinosa J; Muñoz-Hernández O
PLoS One; 2018; 13(1):e0190882. PubMed ID: 29304072
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department.
Morales Ríos O; Jasso Gutiérrez L; Talavera JO; Téllez-Rojo MM; Olivar López V; Garduño Espinosa J; Muñoz Hernández O
Int J Clin Pharm; 2016 Feb; 38(1):80-7. PubMed ID: 26499501
[TBL] [Abstract][Full Text] [Related]
3. Clinical relevance of drug-drug interactions in hospitalized dermatology patients.
Ganeva M; Gancheva T; Troeva J; Kiriyak N; Hristakieva E
Adv Clin Exp Med; 2013; 22(4):555-63. PubMed ID: 23986216
[TBL] [Abstract][Full Text] [Related]
4. Descriptive study of adverse drug reactions in a tertiary care pediatric hospital in México from 2014 to 2017.
Morales-Ríos O; Cicero-Oneto C; García-Ruiz C; Villanueva-García D; Hernández-Hernández M; Olivar-López V; Jiménez-Juárez RN; Jasso-Gutiérrez L
PLoS One; 2020; 15(3):e0230576. PubMed ID: 32208451
[TBL] [Abstract][Full Text] [Related]
5. Expected and actual adverse drug-drug interactions in elderly patients accessing the emergency department: data from the ANCESTRAL-ED study.
Marino A; Capogrosso-Sansone A; Tuccori M; Bini G; Calsolaro V; Mantarro S; Convertino I; Pasqualetti G; Orsitto E; Santini M; Monzani F; Blandizzi C;
Expert Opin Drug Saf; 2016 Dec; 15(sup2):45-50. PubMed ID: 27875918
[TBL] [Abstract][Full Text] [Related]
6. Potential drug-drug interactions in oncological adult inpatients at a Spanish hospital: epidemiology and risk factors.
Fernández de Palencia Espinosa MÁ; Díaz Carrasco MS; Alonso Romero JL; de la Rubia Nieto A; Espuny Miró A
Int J Clin Pharm; 2015 Dec; 37(6):1021-7. PubMed ID: 26391788
[TBL] [Abstract][Full Text] [Related]
7. Are drug-drug interactions a real clinical concern?
Das S; Behera SK; Xavier AS; Dharanipragada S; Selvarajan S
Perspect Clin Res; 2019; 10(2):62-66. PubMed ID: 31008071
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of high-risk drug-drug interactions in paediatric inpatients: a retrospective, single-centre cohort analysis.
Dieu LW; Leuppi-Taegtmeyer AB; van den Anker J; Trachsel D; Gotta V
Swiss Med Wkly; 2019 Aug; 149():w20103. PubMed ID: 31422575
[TBL] [Abstract][Full Text] [Related]
9. How many potential drug-drug interactions cause adverse drug reactions in hospitalized patients?
Bucşa C; Farcaş A; Cazacu I; Leucuta D; Achimas-Cadariu A; Mogosan C; Bojita M
Eur J Intern Med; 2013 Jan; 24(1):27-33. PubMed ID: 23041466
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of three drug-drug interaction screening systems against probable clinically relevant drug-drug interactions: a prospective cohort study.
Muhič N; Mrhar A; Brvar M
Eur J Clin Pharmacol; 2017 Jul; 73(7):875-882. PubMed ID: 28299402
[TBL] [Abstract][Full Text] [Related]
11. Comparison of emergency care delivered to children and young adults with complex chronic conditions between pediatric and general emergency departments.
Murtagh Kurowski E; Byczkowski T; Grupp-Phelan JM
Acad Emerg Med; 2014 Jul; 21(7):778-84. PubMed ID: 25039935
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and risk of potential cytochrome P450-mediated drug-drug interactions in older hospitalized patients with polypharmacy.
Doan J; Zakrzewski-Jakubiak H; Roy J; Turgeon J; Tannenbaum C
Ann Pharmacother; 2013 Mar; 47(3):324-32. PubMed ID: 23482734
[TBL] [Abstract][Full Text] [Related]
13. Drug-drug interactions in pediatric oncology patients.
Balk TE; van der Sijs IH; van Gelder T; Janssen JJB; van der Sluis IM; van Leeuwen RWF; Engels FK
Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 28205376
[TBL] [Abstract][Full Text] [Related]
14. Clinically relevant potential drug-drug interactions among outpatients: A nationwide database study.
Jazbar J; Locatelli I; Horvat N; Kos M
Res Social Adm Pharm; 2018 Jun; 14(6):572-580. PubMed ID: 28716467
[TBL] [Abstract][Full Text] [Related]
15. Drug-drug and drug-disease interactions in the ED: analysis of a high-risk population.
Goldberg RM; Mabee J; Chan L; Wong S
Am J Emerg Med; 1996 Sep; 14(5):447-50. PubMed ID: 8765105
[TBL] [Abstract][Full Text] [Related]
16. Adverse drug reactions caused by drug-drug interactions in cardiovascular disease patients: introduction of a simple prediction tool using electronic screening database items.
Kovačević M; Vezmar Kovačević S; Radovanović S; Stevanović P; Miljković B
Curr Med Res Opin; 2019 Nov; 35(11):1873-1883. PubMed ID: 31328967
[No Abstract] [Full Text] [Related]
17. Prevalence and predictors of potential drug-drug interactions in Regione Emilia-Romagna, Italy.
Gagne JJ; Maio V; Rabinowitz C
J Clin Pharm Ther; 2008 Apr; 33(2):141-51. PubMed ID: 18315779
[TBL] [Abstract][Full Text] [Related]
18. Prevalence, severity, and nature of risk factors associated with drug-drug interactions in geriatric patients receiving cancer chemotherapy: A prospective study in a tertiary care teaching hospital.
Ramasubbu SK; Mahato SK; Agnihotri A; Pasricha RK; Nath UK; Das B
Cancer Treat Res Commun; 2021; 26():100277. PubMed ID: 33348276
[TBL] [Abstract][Full Text] [Related]
19. The prevalence of potential drug-drug interactions in patients with heart failure at hospital discharge.
Straubhaar B; Krähenbühl S; Schlienger RG
Drug Saf; 2006; 29(1):79-90. PubMed ID: 16454536
[TBL] [Abstract][Full Text] [Related]
20. Impact of pharmacists' intervention on identification and management of drug-drug interactions in an intensive care setting.
Hasan SS; Lim KN; Anwar M; Sathvik BS; Ahmadi K; Yuan AW; Kamarunnesa MA
Singapore Med J; 2012 Aug; 53(8):526-31. PubMed ID: 22941130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
